Harm Reduction Strategies for Gay, Bisexual and Other Men Who Have Sex With Men Engaging in Chemsex
Launched by NATIONAL CHENG KUNG UNIVERSITY · Dec 17, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The practice of sexualized drug use is historical and has been noted across a diversity of genders and people of various sexual orientations. The term "chemsex" has been used to specifically describe the use of psychoactive substances in sexualized settings among gay, bisexual, and other men who have sex with men (GBMSM), particularly stimulants like methamphetamine and mephedrone, or other drugs like γ-hydroxybutyrate (GHB), γ-butyrolactone (GBL). Chemsex among GBMSM has coincided with the emergence of sexual-networking mobile apps, creating new opportunities for finding new partners with ...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • individuals need to have a history of drug use (ecstasy, ketamine, crystal methamphetamine, mephedrone, and/or GHB/GBL)in a sexualized context in the previous year
- • can read and understand chinese,
- • willing to communicate with the research team through the mobile messenger app Line.
- Exclusion criteria:
- • None
About National Cheng Kung University
National Cheng Kung University (NCKU) is a prestigious research institution located in Tainan, Taiwan, renowned for its commitment to advancing medical science and innovation. With a strong emphasis on interdisciplinary collaboration, NCKU conducts cutting-edge clinical trials aimed at improving healthcare outcomes and addressing critical health challenges. The university leverages its extensive academic resources and state-of-the-art facilities to foster high-quality research and development, ensuring that its clinical trials adhere to rigorous ethical standards and regulatory compliance. NCKU's dedication to education, research, and community service positions it as a leading sponsor in the field of clinical research, contributing significantly to the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tainan, , Taiwan
Patients applied
Trial Officials
Carol Strong, PhD
Principal Investigator
National Cheng Kung University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported